🏗Vue 3 дляновичков — [2:18:39]
Сейчас Vue — лучший фреймворк для создания пользовательских интерфейсов. По своим возможностям он обходит React и даже Angular.
Это видео поможет вам его освоить на уровне Junior. Автор подробное рассказывает про каждую фичу и показывает её применение на практике.
Перейти к просмотру
#видео#web
#The_Science🇺🇸📕[PDF]⬇️
4 #December2025
#Weekly_Magazines
For learning, for free(dom).
@backupofmagazines
This issue explores a century of quantum mechanics, where breakthroughs in quantum simulators, chemistry modeling, and information hardware illustrate how #QuantumTech and #AI innovation are reshaping modern science. As researchers revisit the Schrödinger equation’s legacy, new discoveries in DNA repair, materials design, and synthetic biology highlight cross-disciplinary shifts fueled by #FutureScience trends. With debates on #SciencePolicy and global collaboration, the issue captures a moment when #ResearchInnovation accelerates faster than ever, redefining both technology and our understanding of reality.
Recent Funding Rounds Overview
🔍Funding Highlights:
- Edera: $15M on Feb 25, 2025. Secure products launch. Learn more
- Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more
- Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more
- Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more
- Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more
- Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more
- BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more
- Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more
- QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more
- Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more
#Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement